X-151397337-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001017980.4(VMA21):c.29A>G(p.Asn10Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000258 in 1,161,699 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001017980.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
VMA21 | NM_001017980.4 | c.29A>G | p.Asn10Ser | missense_variant | 1/3 | ENST00000330374.7 | |
VMA21 | NM_001363810.1 | c.218+280A>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
VMA21 | ENST00000330374.7 | c.29A>G | p.Asn10Ser | missense_variant | 1/3 | 1 | NM_001017980.4 | P1 | |
VMA21 | ENST00000370361.5 | c.218+280A>G | intron_variant | 5 | |||||
VMA21 | ENST00000477649.1 | n.133+690A>G | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.00000883 AC: 1AN: 113236Hom.: 0 Cov.: 24 AF XY: 0.0000283 AC XY: 1AN XY: 35396
GnomAD4 exome AF: 0.00000191 AC: 2AN: 1048463Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 342415
GnomAD4 genome AF: 0.00000883 AC: 1AN: 113236Hom.: 0 Cov.: 24 AF XY: 0.0000283 AC XY: 1AN XY: 35396
ClinVar
Submissions by phenotype
X-linked myopathy with excessive autophagy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 21, 2018 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The serine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with VMA21-related disease. While this variant is not present in population databases, the frequency information is unreliable, as metrics indicate poor data quality at this position in the ExAC database. This sequence change replaces asparagine with serine at codon 10 of the VMA21 protein (p.Asn10Ser). The asparagine residue is weakly conserved and there is a small physicochemical difference between asparagine and serine. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at